ÂÜÀòÂÒÂ×

Dr. Nelson is co-inventor of the Longitudinal Assay Screening technology. He leads the Bio-ID development. Dr. Nelson has over 16 years experience in developing and establishing advanced technologies for biomolecule screening, including 10 years as Manager of Technology Development at GlaxoSmithKline where he ran an interdisciplinary team on the development and optimization of next generation multiplexing technologies. Dr. Nelson holds a Bachelor of Science in Chemistry from the Florida State University and a Ph.D. in Organic Chemistry from the University of Illinois.